Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies. Zurdo-López M, Sagredo Del Rio M, Cháfer Rudilla M, Ibarra A, Doncel-Pérez E Front Neurol. 2026; 17:1815899. PMID: 42111070. Abstract CommentRecommendBookmarkWatch
